secwatch.observer — SEC 8-K summary
======================================

Issuer:     RIGEL PHARMACEUTICALS INC (RIGL)
CIK:        0001034842
Form:       8-K
Filed at:   2024-06-27T23:59:59+00:00
Accession:  0001104659-24-075697
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rigel Pharmaceuticals effects 1-for-10 reverse stock split effective June 27, 2024
--------------------------------------------------------------------------------

- Board approved 1-for-10 reverse split on June 15; effective June 27 at 12:01 a.m. ET.
- Common stock now trades under new CUSIP 766559702.
- No fractional shares issued; cash paid for fractions based on prior-day closing price.
- Stockholders authorized a split ratio range of 1:2 to 1:20 at May 24, 2024 annual meeting.
- Amendment to certificate of incorporation filed with Delaware Secretary of State.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1034842/000110465924075697/0001104659-24-075697-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1034842/000110465924075697/tm2417992d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-075697

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer